These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1603816)

  • 1. Potential role of prostaglandins and leukotrienes in multiple sclerosis and experimental allergic encephalomyelitis.
    Fretland DJ
    Prostaglandins Leukot Essent Fatty Acids; 1992 Apr; 45(4):249-57. PubMed ID: 1603816
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cytokines and chemical mediators in rheumatoid arthritis].
    Miyasaka N
    Nihon Rinsho; 1992 Mar; 50(3):463-7. PubMed ID: 1588732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuroallergy and multiple sclerosis].
    Frick E
    Med Klin; 1967 Apr; 62(17):661-4. PubMed ID: 4875546
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of methallothioneins in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Espejo C; Martínez-Cáceres EM
    Ann N Y Acad Sci; 2005 Jun; 1051():88-96. PubMed ID: 16126947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of cytokines in experimental autoimmune encephalomyelitis.
    Bettelli E; Nicholson LB
    Arch Immunol Ther Exp (Warsz); 2000; 48(5):389-98. PubMed ID: 11140466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Perivenous encephalomyelitis and multiple sclerosis].
    Werner W
    Med Klin; 1969 Oct; 64(42):1924-7. PubMed ID: 5357972
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytokines in the pathogenesis and therapy of autoimmune encephalomyelitis and multiple sclerosis.
    Willenborg DO; Staykova MA
    Adv Exp Med Biol; 2003; 520():96-119. PubMed ID: 12613575
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental allergic encephalomyelitis as a guide to the understanding and treatment of multiple sclerosis.
    Whitaker JN; Mitchell GW
    Ann Neurol; 1993 Nov; 34(5):636-7. PubMed ID: 8239557
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunoglobulins treatment in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Achiron A; Miron S
    Mult Scler; 2000 Oct; 6 Suppl 2():S6-8; discussion S33. PubMed ID: 11188777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Special issue on molecular basis of multiple sclerosis.
    Prat A
    Biochim Biophys Acta; 2011 Feb; 1812(2):131. PubMed ID: 21168062
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetics of experimental autoimmune encephalomyelitis.
    Encinas JA; Kuchroo VK
    Curr Dir Autoimmun; 1999; 1():247-72. PubMed ID: 11791445
    [No Abstract]   [Full Text] [Related]  

  • 12. CD8+ T cells in inflammatory demyelinating disease.
    Weiss HA; Millward JM; Owens T
    J Neuroimmunol; 2007 Nov; 191(1-2):79-85. PubMed ID: 17920696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental autoimmune demyelination. Chronic relapsing models and their therapeutic implications for multiple sclerosis.
    Raine CS; Traugott U
    Ann N Y Acad Sci; 1984; 436():33-51. PubMed ID: 6085228
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunologic determinants of experimental neurologic autoimmune disease and approaches to the multiple sclerosis problem.
    Paterson PY; Fujinami RS; Day ED; Varitek VA; Pescovitz MD; Kelly J; Lorand L
    Trans Am Clin Climatol Assoc; 1978; 89():109-18. PubMed ID: 81557
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immune complexes in multiple sclerosis and experimental allergic encephalomyelitis].
    Vilkov GA; Martirosian VV; Mezhova LI; Mzokova VM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(2):139-42. PubMed ID: 425756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aetiology of multiple sclerosis.
    Colover J
    Lancet; 1981 Aug; 2(8240):260. PubMed ID: 6114312
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of animal models for MS and demyelinating disease in the design of rational therapy.
    Steinman L
    Neuron; 1999 Nov; 24(3):511-4. PubMed ID: 10595504
    [No Abstract]   [Full Text] [Related]  

  • 18. [The nature of the demyelinating process in clinical and experimental neurology].
    Markov DA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(7):967-75. PubMed ID: 5368925
    [No Abstract]   [Full Text] [Related]  

  • 19. The expression and function of chemokines involved in CNS inflammation.
    Ubogu EE; Cossoy MB; Ransohoff RM
    Trends Pharmacol Sci; 2006 Jan; 27(1):48-55. PubMed ID: 16310865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenetic aspects of multiple sclerosis and experimental models of inflammatory demyelination.
    Wisniewski HM; Schuller-Levis GB; Mehta PD; Madrid RE; Lassmann H
    Concepts Immunopathol; 1985; 2():128-50. PubMed ID: 2439203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.